The QLD Government has now released criteria and conditions for 19 prescribed Environmentally Relevant Activities.

There are four critical drivers influencing agriculture's future: affordability, product performance, sustainability and health. These priorities often compete, creating tensions across the value chain.

It is the FDA's practice to issue Warning Letters in order to provide recipients an opportunity to take corrective action.

Recognition of the potential therapeutic benefits of medicinal cannabis for a range of debilitating health conditions has been growing for several years.

NSW drug driving legislation creates an offence to be found with the mere presence of a prescribed drug in their system.

This guide also highlights key legal and commercial issues to consider when doing business in the Asia-Pacific region.

This newsletter includes links and summaries to recent media releases and new developments relating to healthcare law.

Recent amendments under NHA (PB) Bill allow for supply of pharmaceutical benefits to continue after administration or bankruptcy.

The US Food and Drug Administration released draft guidance in late 2013 recommending reducing the use of acrylamide.

Patents containing "Swiss-style" claims are outside the scope of the Australian patent term extension regime.

Activewear retailer Lorna Jane received TGA infringement notices for alleged unlawful advertising relating to COVID-19.

This outcome is likely to restrict the marketing activities of potential infringers in the lead-up to the patent expiry.

Failure to renew will result in cancellation of your registration and limit your ability to export foods to the US.

Many countries across the globe are now opening up legal avenues for the production, sale and consumption of cannabis.

Queensland will implement a three-strike rule for people carrying small amounts of illicit drugs for personal use.

The reality is that it is generally difficult for employers to lawfully dismiss an employee for out of hours conduct.

Over-the-counter access to CBD (cannabidioil) in Australia is one step closer following TGA's latest announcement.

The new Voluntary Assisted dying legislation in NSW will come into effect at the end of 2023.

This second edition outlines key lessons from the global pandemic about IP rights management that businesses can apply.

Banned in 1937, but slowly deregulated, the production of cannabis and its by-product, hemp, has steadily increased.